There are several risk factors associated with the development of ILD in patients with IIMs, such as older age at diagnosis, arthritis/arthralgia, fever, elevated erythrocyte sedimentation rate and C-reactive protein level, presence of anti-Jo-1 antibodies, and presence of anti-MDA5 antibodies [11, 12]. The gene discussed is IFIH1; the disease is interstitial lung disease.